Plantamajoside Inhibits Lipopolysaccharide-Induced MUC5AC Expression and Inflammation through Suppressing the PI3K/Akt and NF- κB Signaling Pathways in Human Airway Epithelial Cells

In conclusion, PMS inhib its LPS-induced MUC5AC expression and inflammation through suppressing the PI3K/Akt and NF-κB signaling pathways, indicating that PMS may be a potential therapy for the treatment of respiratory inflammatory diseases.
Source: Inflammation - Category: Allergy & Immunology Source Type: research